Chondrocyte proliferation and differentiation pathways in articular cartilage

Chondrocyte proliferation and differentiation pathways encompass the coordinated molecular signals that govern the lifecycle of chondrocytes within articular cartilage. These pathways, including Fibroblast Growth Factor (FGF), Transforming Growth Factor-beta (TGF-β)/Bone Morphogenetic Protein (BMP), Wnt/beta-catenin, and Indian Hedgehog (IHH)/Parathyroid Hormone-related Protein (PTHrP) signaling, are critical for maintaining the structural integrity and functional properties of the cartilage extracellular matrix (Mackie et al., 2008, Endocrine Reviews). In healthy articular cartilage, chondrocytes typically maintain a stable, non-hypertrophic phenotype; however, pathological shifts toward terminal differentiation and hypertrophy are central to the progression of degenerative joint diseases like osteoarthritis (van der Kraan & van den Berg, 2012, Nature Reviews Rheumatology). Therapeutic interventions targeting these pathways, such as the FGF18 analog Sprifermin or the C-type natriuretic peptide analog Vosoritide, aim to either stimulate the regenerative capacity of chondrocytes or inhibit the degradative processes associated with hypertrophy (Savarirayan et al., 2019, NEJM). Consequently, these pathways represent a broad therapeutic landscape for regenerative medicine and the development of disease-modifying osteoarthritis drugs (DMOADs).

Other names

Chondrogenesis signaling pathwaysArticular cartilage development pathwaysChondrocyte maturation processEndochondral ossification regulatory network

Modulation of growth factor signaling cascades (e.g., FGF, TGF-beta, Wnt) to regulate chondrocyte entry into the cell cycle and subsequent maturation into hypertrophic cells.